ZEAL Network SE Elevator Pitch: Key Takeaways
ZEAL Network SE – Inside the Future of Digital Lottery
Presented by CFO Andrea Behrend on seat11a.com
Business Model, Market Dominance & Bold Strategy
CFO Andrea Behrend takes us inside ZEAL’s powerful business model, market dominance, and bold strategy to redefine the future of lottery as a thrilling digital-first experience with innovative offerings.
A 25-Year Evolution into a Lottery Tech Powerhouse
Founded over 25 years ago, ZEAL has evolved into a lottery tech powerhouse. With more than 1.4 million active monthly users, a market cap of over €1 billion, and €382 million contributed to good causes in 2024 alone, ZEAL merges tech innovation with social purpose. And it doesn’t stop there. The average monthly billing per user stands at €63, showcasing the brand’s strong consumer engagement and lifetime value model.
“We’re not just selling lottery tickets. We’re selling dreams,” says CFO Andrea Behrend — and those dreams are delivered with German efficiency and digital sophistication.
Core Business: B2C Lottery Brokerage Model
At the heart of ZEAL’s business is its core B2C lottery brokerage model, operating under the popular consumer brands Lotto24 and Tipp24. These platforms offer licensed access to Germany’s beloved state lotteries such as Lotto 6aus49 and EuroJackpot, but with the added convenience, speed, and security of e-commerce. ZEAL doesn’t take on jackpot risks — it earns through brokerage commissions and service fees, while state lotteries handle prize payouts.
Why Do Users Love ZEAL?
Because it’s a 24/7 digital lottery experience, secure (no more lost tickets), fully mobile, with automatic prize notifications, personalised offers, and a suite of traditional, social, and instant-win products. Whether you’re dreaming of a €120 million EuroJackpot or a luxury home in Bavaria through the Traumhausverlosung, ZEAL makes lottery participation simple, meaningful, and exciting.
Strategic Differentiators
44% market share in German online lottery brokerage
High customer retention and lifetime value (up to 20+ years)
Diversified revenue via new product lines such as:
freiheit+ (social lottery with strong charity partners)
Traumhausverlosung (luxury house raffles)
Virtual Games (now over 580 live titles)
Market Opportunity
The total German lottery market is estimated at €10 billion, with an online penetration rate of only 29% — significantly behind sectors such as music streaming (81%) and banking (67%). ZEAL forecasts online lottery penetration rising to 50–70%, which would expand the digital market to €5–7 billion.
ZEAL’s Ambition
Capture 50% of that online market, which would mean €2.5–3.5 billion in annual billings — more than double today’s level. With a highly scalable business, 80–85% of additional revenue is directly attributed to the EBITDA line, providing ZEAL with a clear pathway to margin expansion and increased shareholder value.
Shareholder Benefits
Strong cash generation & stable EBITDA
Attractive dividend policy + share buybacks
Exposure to a digital-native platform in a growing regulated market
High data-driven predictability and CRM-driven user retention
A Digital Platform Blending Profitability with Purpose
Whether it’s recurring player cohorts, record-breaking jackpot years (such as 2024, with 13 peak jackpots), or expansion into new game categories, ZEAL is positioning itself as a dominant, resilient, and deeply trusted lottery technology platform...
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Kontron AG H1 2025 – Long-Form Financial Summary
Presented by CFO Clemens Billek on seat11a.com
Strong Financial Performance with Raised Full-Year Outlook
In the first half of 2025, Kontron AG delivered standout financial performance under the leadership of CFO Clemens Billek. The company not only achieved rapid earnings growth but also demonstrated operational stability and momentum across its IoT, embedded computing, and software solutions segments—strong enough to raise its full-year profit guidance.
1. Financial Performance & Margin Improvement
EBITDA: Surged by 78.2% to €146.0 million
Reported EBITDA Margin: 18.7% (up from 10.5%)
Adjusted (Underlying) Margin: ~12.6%
Net Income (after minority interests): €88.9 million (up from €37.9 million)
EPS: Increased to €1.45 (from €0.61)
Key drivers included non-recurring gains from the deconsolidation of the COM business and the increasing share of revenue from the “Software + Solutions” segment, which rose to 34.7% of total revenue (up from 29.9%).
2. Order Backlog, Book‑to‑Bill Ratio & Cash Flow
Order Backlog: €2,278 million (up from €2,078 million at year-end)
Book‑to‑Bill Ratio: Improved to 1.26
Operating Cash Flow: Positive €16.3 million (vs. –€16.8 million in prior year)
Equity: Rose to €688.3 million
Equity Ratio: Improved to 38.1% (from 35.8%)
The return to positive operating cash flow marks a key financial turning point, offering more flexibility for strategic investment and M&A. Strengthened equity metrics signal a solid and improving balance sheet.
3. Raised Guidance & Investor Implications
In light of the strong H1 2025 performance, Kontron raised its full-year profit forecast:
New EBITDA Target: At least €270 million (up from €220 million)
Revenue Guidance: Adjusted to ~€1,800 million (from €1,900–2,000 million), due to portfolio deconsolidation
This signals that while the topline is being recalibrated, the business mix is shifting toward higher profitability and improved margins—supporting investor confidence in earnings quality and strategic discipline.
Strategic Context: What This Means Going Forward
Expansion in “Software & Solutions” mix reflects strategic shift to stable, high-margin revenue streams.
Deconsolidation and portfolio simplification improve transparency and profit conversion.
Order intake and backlog growth point to sustained demand in core IoT verticals: transportation, industrial automation, and telecom infrastructure.
Positive cash flow and stronger equity position prepare Kontron for continued organic and inorganic growth.
Key Takeaways for Investors
Remarkable EBITDA growth (+78.2%) and margin uplift after adjusting the portfolio
Greater emphasis on recurring, high-margin revenue via “Software + Solutions”
Significant improvement in operating cash flow and financial flexibility
Upgraded profit guidance reflects accelerating earnings momentum
Stronger operational execution and strategic clarity increase investor confidence
Conclusion
Kontron AG’s first half of 2025 shows disciplined execution, enhanced profitability, and strategic reorientation toward more stable, scalable business lines. With raised EBITDA guidance and a focus on high-margin growth, the company is positioned to continue delivering value to shareholders—both in the short term and beyond.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Hypoport SE Deep Dive: Key Takeaways
📊 Hypoport Deep Dive Q&A with CEO Ronald Slabke
Answering the Three Most Pressing Institutional Investor Questions
Presented on seat11a.com
🎯 Focused Q&A Format for Institutional Investors
In an exclusive and uniquely focused session, Ronald Slabke, CEO of Hypoport SE, engages in a transparent and deeply analytical conversation centred on the three most pressing questions raised by institutional investors. Instead of providing broad operational updates, Slabke concentrates on long-term strategy, structural market trends, and Hypoport’s positioning in Germany’s financial services landscape.
🏡 1. Why Will the German Mortgage Market Outperform Inflation Over the Long Term?
Slabke outlines how Germany’s housing demand has evolved since the European free labour movement began in 2011. Net migration from Southern and Eastern Europe has created long-term demand in urban centres, outpacing supply. The rental market is constrained by regulation, pushing more households toward homeownership.
Key structural drivers:
Low homeownership rate (42%) is rising due to changing demographics and investor exit trends
Expected recovery in new construction as pricing stabilizes
Upcoming refinancing wave from expiring fixed-rate loans
Massive potential for green home investments tied to Germany’s 2050 decarbonization targets
Despite interest rate-driven slowdowns in 2022, prices have rebounded—especially in metro areas like Berlin. Slabke sees a path toward €100 billion in quarterly mortgage volumes and home prices continuing to rise above inflation.
💻 2. What Makes the Europace B2B Mortgage Platform So Critical?
Europace has evolved from a product marketplace into a comprehensive SaaS-powered infrastructure, integrating over 1,000 banks and thousands of advisors. It’s a Salesforce-meets-eBay style digital ecosystem tailored for mortgages.
Key platform enhancements:
Agent and real estate integration to support mortgage closings
Consumer apps for document uploads, price discovery, and 1-click approvals
AI-driven fraud detection, underwriting, and instant credit decisioning
With Europace dominating regional banks and broker networks, and no credible competitor in sight, it is the undisputed backbone of Germany’s mortgage industry—central to Hypoport’s long-term value.
🔄 3. Why Did Hypoport Diversify Beyond Mortgages—and Was It the Right Move?
Hypoport expanded into insurance and other B2B finance sectors to replicate Europace’s success. While these sectors offer long-term promise, results have varied due to differing market readiness and regulation.
Key takeaways from Slabke’s assessment:
Diversification adds resilience and optionality
Not all verticals are equally scalable or receptive to platforms
Hypoport is now focusing on B2B markets where category leadership is achievable
This marks a shift back to core strengths, ensuring that Hypoport doubles down where its platform model can dominate, rather than spreading resources across less strategic segments.
🧠 Conclusion: A Clearer, Stronger Hypoport for the Future
Slabke’s answers deliver a compelling message to long-term investors: Hypoport is structurally aligned with Germany’s most resilient market—housing—and owns the infrastructure to lead it.
With renewed focus on automation, consumer-centric workflows, and platform dominance, Hypoport is positioned to scale even in a high-rate environment. Its strategic clarity and executional discipline support sustainable long-term growth.
seat11a.com continues to be the destination for investor-centric insights, and this session underscores Hypoport’s role as one of Germany’s most innovative, infrastructure-critical fintech firms.
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
eDreams ODIGEO's Q1 2025 Key Takeaways
eDreams ODIGEO Q1 FY 2026 – Executive Summary
Presented by CFO David Elizaga on seat11a.com
Strong Start to FY 2026 with Subscription Model at Core
eDreams ODIGEO kicked off its financial year 2026 with a powerful performance that once again reinforces the strength of its subscription-based travel model. CFO David Elizaga presented a highly confident outlook, supported by solid subscriber growth, improved profitability, and continued strategic execution.
Prime: The Growth Engine
At the heart of this success is Prime, eDreams’ unique travel subscription service. With 7.5 million subscribers now onboard, Prime has become the company’s core growth engine. In the first quarter alone, the firm added over 200,000 new subscribers, reaching the upper end of their guidance.
This strong growth is not just about volume—it’s also about quality: renewals continue to increase as the member base matures, making the overall model more cost-efficient and highly profitable over time.
Financial Momentum
This growth in Prime has translated directly into substantial earnings momentum. The company delivered strong increases in both adjusted net income and EBITDA, building on the gains seen in the previous year. As Prime now accounts for around three-quarters of total revenue, eDreams is less exposed to volatile travel pricing and more focused on predictable, high-margin recurring income.
Operational Leverage and Strategic Transformation
Elizaga emphasized that the transformation of eDreams ODIGEO from a transactional to a subscription-based travel business is well ahead of schedule. Operating leverage is improving as acquisition costs drop per subscriber, and profitability continues to scale in line with revenue growth. This demonstrates the power of Prime to reshape not only the company’s income structure but the entire economics of travel booking in Europe and beyond.
Capital Markets Update
From a capital markets perspective, the company also launched a new €20 million share buyback programme, underlining its commitment to shareholders. This follows the near completion of the previous buyback effort, and it comes at a time when liquidity in the stock has markedly improved.
FY 2026 Outlook
Looking forward, the full-year EBITDA guidance of €215 to €220 million has been reaffirmed, representing a near doubling compared to the previous year. Management also remains confident in hitting its Prime subscriber target of 8.25 million by the end of FY 2026, with the long-term ambition to grow the subscriber base by approximately 10% annually.
Conclusion by CFO David Elizaga
Elizaga concluded his presentation by highlighting the company’s position as a pioneer in the travel tech space. The model is not only working—it is accelerating. With Prime’s scale, efficiency, and customer loyalty on the rise, eDreams ODIGEO is entering a new phase of growth, profitability, and shareholder value creation.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
LEG Immobilien SE – Affordable Housing with Impact and Long-Term Upside
Presented by Frank Kopfinger, Head of Investor Relations and Strategy
In this compelling elevator pitch on seat11a.com, Frank Kopfinger, Head of Investor Relations and Strategy at LEG Immobilien SE, delivers a clear and data-backed insight into one of Germany’s leading residential real estate companies.
🏢 Who is LEG Immobilien SE?
- LEG is Germany’s second-largest pure-play residential real estate company, managing a portfolio of approx. 172,000 units and housing nearly 500,000 tenants.
- LEG operates exclusively in Germany, with a strong regional focus: ~80% of assets are located in North Rhine-Westphalia (NRW) — the country’s most populous state and an economic powerhouse accounting for 22% of German GDP.
- LEG’s strategy is laser-focused on a single asset class: affordable living — a segment with high societal relevance and strong structural demand.
💡 Core Value Proposition: Affordable Housing with Impact
- Average tenant rent: €6.90/m² or about €440/month per household
- 17% of units are rent-restricted, often with state subsidies
- LEG’s approach serves a vital role in tackling Germany’s housing shortage and supports lower-income households while delivering consistent returns
- The portfolio is attractively valued at €1,656/m², significantly below estimated replacement costs of €4,000–5,000/m² (excluding land)
💰 Valuation & NAV Opportunity
- Net Tangible Assets (NTA) per share stand at ~€131
- Compared to the current market price of €73, this represents a ~44% discount
- Kopfinger notes that this valuation gap reflects past interest rate-driven headwinds, but believes the worst is behind them
📈 Crisis Management: From Defensive to Offensive
- LEG navigated recent macro pressures with clear, cash-focused steering and strict financial discipline:
- Shifted core KPI to AFFO (Adjusted Funds from Operations), the sector’s proxy for free cash flow
- Suspended dividend in FY 2022 to conserve capital
- Issued scrip dividends in 2023 and 2024, preserving over €100 million in cash
- Sold >5,700 non-core units since 2023 for >€550 million, often at or above book value
- Halted new development pipeline — last new units to be completed by the end of 2025
- Opportunistically refinanced debt, achieving an average financing cost of 1.54%
- Maintained LTV (Loan-to-Value) at 47.6%, with further deleveraging underway
🏗️ Growth Outlook: Structural Tailwinds Remain Strong
- Germany’s housing sector remains severely undersupplied — and LEG is well-positioned to benefit:
- The supply-demand imbalance continues to widen, with construction output declining
- LEG expects further organic rent growth, driven by:
- Ongoing market rent adjustments
- Cost rent adjustments in subsidised units (2026)
- Expiry of rent restrictions on ~16,000 units by 2028, creating value uplift potential
- LEG also diversifies income through services: energy, multimedia, and maintenance
🔄 Capital Allocation: Predictable and Yield-Oriented
- LEG’s dividend policy is anchored on 100% of AFFO payout
- Also shares proceeds from disposals of non-core assets
- In 2025, LEG narrowed its AFFO guidance to €215–225 million, indicating an expected YoY increase of ~10% at the midpoint
🎯 Strategic Positioning: A Play on Resilience and Social Relevance
- LEG delivers high earnings stability across the cycle
- FFO I and AFFO metrics in 2025 are already back at pre-crisis levels
- Despite macro headwinds, LEG has maintained operational profitability, preserved liquidity, and defended its balance sheet
- The portfolio remains well-balanced across regions, with 67% in normal rent markets and 33% in tense markets — limiting regulatory downside
T&C
www.seat11a.com/legal
JOST Werke SE H1 2025: Key Takeaways
Q2 2025: Resilience, Strategic Focus, and Hyva PMI Integration
🔹 Strong Group-Level Performance
- Total sales reached €391 million, including €109 million from the Hyva hydraulics segment (excluding crane business).
- Organic sales declined slightly by -3%, reflecting a challenging global demand environment.
- Adjusted EBIT increased by 9.5% to €37 million, supported by resilient aftermarket sales and the positive impact of discontinuing the crane segment.
- Adjusted EBIT margin improved to 9.8%, thanks to effective cost control and portfolio optimisation.
🔹 Regional Trends
- EMEA: Sales grew by 3.7% year-over-year, with EBIT margin rising to 5.8%, indicating market stabilisation.
- Americas: Sales fell by 11.1% due to tariff uncertainty, while profitability remained solid at 11.0% EBIT margin.
- APAC: While sales were down 10.2%, strong growth in Agriculture and OEM partnerships in South America and APAC supported a recovery. EBIT surged by 80.7%, driven by long-term contracts and margin expansion.
🔹 Strategic Highlights
- Crane Business Exit: Sale and Purchase Agreement (SPA) signed on August 11, 2025, with closing expected in Q4.
- Hyva PMI Integration: Integration is proceeding well, with synergies already being implemented.
- Financing: Successful issuance of a €320 million promissory note loan during the quarter, improving the maturity profile at favourable rates.
🔹 Outlook for FY 2025
- Confirmed and specified:
- Sales (continued operations): Expected to grow by 40–50% YoY
- Adjusted EBIT: Increase by 23–28% YoY
- Adjusted EBITDA: Increase by 23–28%
- CapEx: Approximately 2.9% of sales
- Working capital: Targeted below 18.5% of sales
- Including discontinued operations (cranes): Sales growth outlook rises to 50–60% and EBIT to 25–50%, depending on deal closure timing.
🔹 Key Messages
- Despite macroeconomic pressures, JOST’s diversified business model—spanning geographies, industries, and customer bases—proved effective in mitigating risk and stabilising margins.
- The aftermarket and Agricultural segments offer strong potential for further growth.
- M&A and local market share gains remain central to JOST’s long-term strategy.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Hypoport SE H1 2025: Key TakeawaysHypoport SE H1 2025: Rebounding Stronger in Germany’s Digital Finance EcosystemPresented by Ronald Slabke, CEOIn his H1 2025 presentation on seat11a.com, Ronald Slabke, CEO of Hypoport SE, outlines a strong rebound in operating performance, signalling a continuation of the recovery that began in late 2024. With double-digit revenue growth, a 94% increase in EBIT, and stable platform expansion, the digital financial service provider reinforces its leadership in Germany’s mortgage and real estate ecosystems.H1 2025 Key Financial Figures (Adjusted): - Revenue: approx. €305 million (+13% YoY) - Gross Profit: approx. €130 million (+14% YoY) - EBIT: approx. €16 million (+94% YoY) - EBIT Margin: significantly improved - Free Cash Flow: positive trend continuedQ2 2025 Highlights: - Revenue: approx. €146 million (+6% YoY) - Gross Profit: approx. €64 million (+13% YoY) - EBIT: approx. €7.4 million (nearly 2x YoY)CEO Ronald Slabke’s Commentary: “The growth trajectory that began with the private mortgage market rebound in 2024 continues into the first half of 2025. Our platforms—especially Europace, Finmas, and Genopace—are benefiting from both market recovery and stronger partner engagement. Our digital ecosystem is gaining depth, and we are becoming increasingly indispensable to our partners.”Platform and Segment Highlights: Real Estate & Mortgage Platform (Europace, Finmas, Genopace): - Core growth driver in H1 2025 - Transaction volume grew faster than the market average - Productivity improvements for banks, brokers, and insurers - Increased automation and better customer journeys attracted new partners - Continued scaling in cooperative banking segments - Financing Platform (B2B Lending): Stable but slower growth - Mixed performance across corporate lending and development financing - Cost control measures offset margin pressure - Focus on digitising manual processes - Insurance Platform: Solid user base, modest revenue growth - Further digital product investments underway - Evaluating enhanced cross-platform capabilities with mortgage platforms Real Estate Platform: - Slight uptick in transaction-based revenue - Lower asset rotation in institutional real estate segment - Preparing to integrate deeper ESG metrics into listings and analytics - Steady partner base growth in mid-sized housing segment Strategic Themes Driving Momentum: - Continued digitisation of real estate financing in Germany - Platforms like Europace becoming essential infrastructure - Regulatory pressures driving demand for compliance automation - Strengthening network effects between banking and insurance partners - Record-high customer loyalty metrics Financial Stability and Operational Leverage: - Improved operating leverage from higher platform utilisation - Disciplined hiring focused on product and technology - Ongoing cost focus with targeted R&D investment - Conservative capital allocation prioritising organic growth and profitability▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Mutares SE Elevator Pitch: Key Takeaways
🔍 Who is Mutares?
Mutares is a global private equity specialist focused on distressed carve-outs and special situations. The firm, headquartered in Munich, is family and owner-managed, with around 40% of shares held by management, ensuring strong alignment with shareholder interests.
“We take what others discard and transform it into something of value,” says CIO Johannes Laumann, encapsulating Mutares’ unique and entrepreneurial approach that sets it apart in the private equity landscape.
💼 Core Strategy
Mutares thrives on entrepreneurial transformation. It acquires non-core assets from corporates—typically underperforming, unloved businesses—and restores them through active hands-on restructuring. With ~160 operational experts embedded in the portfolio companies, Mutares drives turnaround from the inside out.
🌍 Global Expansion & Footprint
By 2025, Mutares is set to further its global reach, establishing new offices in Chicago, Tokyo, Mumbai, and Shanghai, in addition to its strong European base in cities like Frankfurt, Milan, Paris, and Helsinki. This expansion instils optimism for the company’s future growth and success.
This local presence enables deal sourcing and execution on a global scale, with expert understanding of regional nuances and distressed asset opportunities.
📦 Diversified Portfolio
Mutares segments its ~33 portfolio companies into four balanced sectors, mitigating cyclical risk:
- Automotive & Mobility – €2.8 bn annualized revenue
- Engineering & Technology – €1.5 bn annualized revenue
- Goods & Services – €1.6 bn annualized revenue
- Infrastructure & Special Industry – €1.4 bn annualized revenue
- These sectors span early-, late-, and non-cyclical industries, giving Mutares flexibility to buy and sell across market environments.
📈 Outlook 2025
Following years of dynamic growth, Mutares enters a new strategic phase focused on profitable exits and global consolidation:
- Transaction Pipeline: Over €200 million in gross exit proceeds targeted
- Revenues (Group): €6.5 to €7.5 billion
- Holding Net Income: €130 to €160 million
- EPS Target: €7 per share
- Mid-Term Goal: €200 million net income → €9 EPS
- Market Cap Vision: €1 billion
- Revenue Vision: €10 billion Group turnover
Laumann emphasises:
“We’re not a fund. We don’t have to exit on a clock. We sell when it makes sense.”
📌 Segment Outlook
- Automotive & Mobility: Consolidation and preparing large platforms for exit
- Engineering & Technology: Expansion driven by energy, infrastructure, and the “Trump effect” in industrial policy
- Infrastructure & Special Industry: Strong momentum in defence and logistics
- Goods & Services: Reliable, non-cyclical services with niche leadership
💰 Capital Allocation & Dividends
Mutares follows an attractive dividend policy:
Base Dividend: €2.00 per share
Performance Dividend: Additional payout from significant exits
Bond Investors: Access to double-digit returns with bonds maturing in 2027 and 2029, listed in Frankfurt and Oslo
🧩 Why Invest in Mutares?
- Leading European player in carve-out restructuring
- Globally diversified transaction and portfolio platform
- Hands-on, entrepreneurial turnaround strategy
- Management is personally invested
- Clear roadmap to €200m+ profits and €10bn turnover
- Strong alignment of shareholder value and sustainable growth
“With one share in Mutares, you’re exposed to 33 companies across industries—and we’re just getting started,” concludes Laumann.
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Mutares SE Deep Dive: Key Takeaways
🧩 Segment-by-Segment Strategic Outlook
1. Automotive & Mobility
Focus on consolidation and exit readiness for two major portfolio groups. Selected expansion will occur only where highly accretive. The segment remains a major revenue contributor (~€2.8 billion annualized).
2. Engineering & Technology
Described by Laumann as benefiting from the “Trump effect”, this segment rides the wave of infrastructure and energy capex, including investments in both traditional and renewable energy sectors. Exposure to high-demand fields like defense, chemicals, and logistics positions Mutares for deep value creation here.
3. Infrastructure & Special Industry
Dubbed the “home run” segment, this unit has proven resilient and profitable, especially through recent geopolitical shifts. With growing demand for logistics and defense equipment, Mutares is expanding its industrial presence in this vertical, with about €1.4 billion in annualized revenue across 7 companies.
4. Goods & Services
This segment is viewed as non-cyclical and plannable, delivering recurring revenues from industrial services. The team continues to scale existing operations, dominate niche markets, and consolidate fragmented sub-sectors across Europe.
🌍 Global Reach & Portfolio Diversification
With offices in Tokyo, Shanghai, Mumbai, Chicago, and Helsinki, Mutares now boasts over 35 companies across 4 continents, creating a balanced and diversified platform. Annualized group revenue is now over €7 billion, and the firm’s average holding period of 3–5 years allows for deep operational turnaround and exit readiness.
Mutares follows an active ownership model focused on:
- Deep operational engagement
- Cost transformation and synergy creation
- Exit multiple enhancement (ROIC target of 7–10x)
💰 Capital Structure & Dividend Policy
Mutares offers investors access to the private equity space through:
- An attractive dividend strategy: €2.00 base dividend plus performance dividend
- Listed bonds maturing in 2027 and 2029
- A goal to grow market cap to €1 billion
- A long-term net income target of €200 million
The company also pursues sustainable management practices, operating as a family- and owner-managed enterprise, with strong alignment between management and shareholders.
✅ Key Takeaways
- €130–160 million net income targeted for 2025
- €6.5–7.5 billion in group revenue guidance
- Over €200 million in exit proceeds expected
- Expansion in North America and Asia
- New growth from infrastructure, defense, chemicals, and logistics
- Strategic consolidation in Automotive & Mobility
- Mutares aims for €10 billion in revenues and €200 million in profit
Laumann concluded by reiterating Mutares’ unwavering commitment to growth, value creation, and a shareholder-aligned model. With its buy-build-exit approach and sector-diversified structure, Mutares is positioning itself as a global leader in special situations and distressed carve-outs, ensuring a secure and prosperous future for all stakeholders.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
LEG Immobilien SE: H1 2025 Financial Performance HighlightsPresented by Frank Kopfinger, Head of Investor RelationsIn his H1 2025 presentation on seat11a.com, Frank Kopfinger outlines a solid half-year performance for the group, emphasising double-digit AFFO growth, high occupancy, and strategic progress in sustainability and capital structure. Despite persistent macroeconomic challenges, LEG remains one of Germany’s most reliable and resilient residential real estate platforms.Financial Highlights H1 2025 (vs. H1 2024): Rental Income: €579.5m vs. €568.0m (+2.0%) Net Cold Rent: €549.0m vs. €537.7m (+2.1%) Funds from Operations (FFO I): €202.7m vs. €202.0m (+0.3%) Adjusted FFO (AFFO): €143.8m vs. €130.1m (+10.5%) AFFO per share: €2.13 vs. €1.93 (+10.4%) Loan-to-Value (LTV): 43.5% vs. 44.3% (Improved) Occupancy Rate: 99.0% (Stable)Key Takeaways: AFFO growth of 10.5% YoY reflects high rental stability and disciplined cost control Net cold rent increase supported by modernisations, indexation, and robust occupancy Maintenance and operating costs well managed, contributing to stable margins CapEx focus remains disciplined, with selective, ESG-aligned modernisation Dividend payout ratio tied to AFFO for long-term investor confidencePortfolio Performance: ~167,000 residential units focused on affordable housing in German urban and suburban areas Like-for-like rent growth of 3.1% despite regulatory headwinds Re-letting rent growth of 4.5% in dynamic locations Strong demand and low supply in core marketsESG & Sustainability Strategy: Modernisation rate at 2.6% of portfolio (targeted, cost-effective upgrades) Focus on climate-efficient buildings and tenant-centred refurbishment CO₂ intensity reduction remains a strategic priority Strategy supports tenant loyalty, compliance, and long-term valuationBalance Sheet & Capital Structure: LTV improved to 43.5%, enhancing financial flexibility Average debt maturity extended to 8.6 years, average interest cost 1.57% No major refinancing needs until 2026 Continued moderate deleveraging via retained earnings and disciplined cash flowFull-Year 2025 Guidance (Confirmed): AFFO: €265–280 million AFFO per share: €3.90–4.10 Dividend: Based on 100% AFFO payout Continued CapEx discipline and operating stabilityFinal Outlook from Frank Kopfinger:“We continue to deliver on what LEG is known for: stable, predictable results, responsible capital management, and value creation for all stakeholders. Our strong operational base gives us the flexibility to grow responsibly in a changing environment.”▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Carl Zeiss Meditec AG 9M 2024/25: Key Takeaways
Carl Zeiss Meditec: 9M 2024/25 Financial Performance Update
Presented by Sebastian Frericks, Head of Investor Relations
Sebastian Frericks, Head of Investor Relations at Carl Zeiss Meditec, presents a strong nine-month performance for the fiscal year 2024/25, underscoring strategic progress, rising order momentum, and margin stabilisation across key markets. Despite ongoing macroeconomic challenges, the group maintains its outlook and continues to invest in innovation and growth initiatives.
📊 Key Financial Highlights (9M 2024/25 vs. PY):
- Revenue: €1,699.5 million (+7.6%)
- Order Entry: €1,600.1 million (+23.3%)
- EBITA: €175.4 million (+3.1%)
- EBITA Margin: 11.0% (PY: 11.4%; adjusted: 11.1%)
- Operating cash flow: Increased YoY
- Net Financial Debt: -€384.1 million (due to shareholder loan)
Revenue was boosted by solid Q3 growth, and order entry surged due to a strong performance in both equipment and recurring business across all regions. However, the company faced challenges from U.S. tariffs and FX risks, which affected the revenue and margin. Despite these headwinds, the underlying operating performance remained robust.
🔬 Segment Performance:
👁️ Ophthalmology (OPT)
- Revenue: €1,251.1m (+9.5%)
- EBITA Margin: 10.6% (up +1.6pp)
- Margin uplift was driven by growth in refractive consumables and the successful integration of DORC
- Strong IOL (intraocular lens) volume growth in China despite pricing pressure from volume-based procurement (VBP)
🧠 Microsurgery (MCS)
- Revenue: €349.0m (+1.6%)
- EBITA Margin: 12.3% (down -7.3pp)
- Performance impacted by product transition to the new KINEVO® 900 S, lower neurosurgical volumes, and FX tariffs
🌍 Regional Highlights:
- Americas: €407.5m (+14.2%) – Driven by DORC consolidation and organic growth
- EMEA: €482.8m (+11.7%) – Strong in Germany, UK, Nordics
- APAC: €709.9m (+1.8%) – Southeast Asia and India positive; Japan down; China stable
🚀 Strategic Growth Drivers:
🔹 VISUMAX® 800 and SMILE® pro
- Now >20% of the global installed base
- Over 50 systems installed in China, with SMILE® pro surpassing 10,000 procedures
- ZEISS holds ~50% share of the Chinese refractive market, positioning itself as the #1 total solution provider
🔹 DORC Integration
- Strong YTD contribution with order funnel expansion
- ILM-Blue® approved in China
- Integration of sales forces progressing, especially in APAC
- Targeting EVA Nexus expansion in dual accounts and vitrectomy procedures
🔹 Digital & Surgical Milestones
- VERACITY Surgery Planner used in >2 million planned cataract surgeries in the U.S.
- PENTERO® 800 S and ILM-Blue® approved by Chinese NMPA
- VISUMAX® / SMILE® recognised with the Berthold Leibinger Innovation Prize
💡 Operational Efficiency & Cost Management:
- OpEx reduction through lower R&D and integration costs
- Investments in IT and marketing increased slightly
- Admin costs up due to DORC consolidation
- EBITA margin recovery achieved even with external headwinds
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Wacker Chemie AG H1 2025: Key Takeaways
Wacker Chemie AG: Q2 2025 Financial Results
Presented by Joerg Hoffmann, CFA – Head of Investor Relations
In this detailed financial update, Joerg Hoffmann, CFA, Head of Investor Relations at Wacker Chemie AG, presents the company’s performance for Q2 2025. While the group navigates persistent macroeconomic headwinds, FX volatility, and softer demand, Wacker remains strategically focused and financially stable with a strong balance sheet and proactive measures to improve profitability.
📊 Q2 2025 Financial Summary:
Metric Q2 2025 Q2 2024 YoY Change
Sales €1.41bn €1.47bn -4%
EBITDA €114m €155m -26%
EBIT -€11m €38m n.a.
Net Income -€19m €35m n.a.
EBITDA Margin 8.1% 10.5%
CapEx €96m €177m -46%
Net Financial Debt €1.14bn €661m +72%
Joerg Hoffmann attributed the earnings decline primarily to weak volume and pricing effects, unfavourable FX developments, and a planned turnaround in Polymers. Additionally, elevated working capital and dividend payments contributed to the higher net debt.
🌍 Strategic Context & Outlook:
Due to continued geopolitical uncertainty, trade-related volatility, and a challenging global economic environment, Wacker has lowered its full-year 2025 guidance:
Sales now expected between €5.5–5.9 billion (previously €6.1–6.4 billion)
EBITDA expected between €500–700 million (down from €700–900 million)
To address these challenges, Wacker is implementing a 3-part strategy:
Growth: Intensify sales and innovation focus
Cash: Optimise working capital and reduce investment
Cost: Improve productivity and utilisation rates across sites
🔬 Segment Performance Highlights:
🧪 Silicones
Sales: €713m | EBITDA: €104m
Volumes higher YoY, but pricing and FX impacts continued
Supported by insurance compensation for supply chain disruptions
FY outlook: sales and EBITDA at prior-year level
🧱 Polymers
Sales: €363m | EBITDA: €40m
Weaker construction demand in Europe and China
VAM turnaround impacted results
FY outlook: slight sales decline, stable margins
🧫 Biosolutions
Sales: €87m | EBITDA: €5m
Market softness continued, though the BENEO partnership for human milk oligosaccharides was initiated
FY outlook: stable sales and EBITDA
☀️ Polysilicon
Sales: €218m | EBITDA: €34m
Strong semi-grade sales, but solar volumes down due to U.S. tariffs and policy uncertainty
Focus remains on cost and cash management
FY outlook: flat sales, EBITDA ~€100m
💰 Balance Sheet & Liquidity:
Equity: €4.5bn (down €335m due to FX and dividend)
Liquidity: €796m cash and securities
CapEx: €96m in Q2, aligned with strategic spend reduction
Pension liabilities: reduced to €692m
Wacker’s financial health remains strong, with ample liquidity, although net debt rose to support dividends and investments.
🌱 Sustainability & ESG Progress:
Product carbon footprints (PCFs) are now provided to customers
Progress in reducing CO₂e emissions, water, and energy consumption
Targets remain in place for Net Zero by 2045
Continued focus on diversity, supplier sustainability, and safety
🔭 Outlook & Key Message from Joerg Hoffmann:
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
ZEAL Network SE H1 2025: Key TakeawaysZEAL Network SE: Digital Growth Momentum Continues in H1 2025Presented by CFO Andrea Behrendt on seat11a.comZEAL Network SE continues its strong digital performance in H1 2025 with an impressive 76% growth in EBITDA, expanding customer numbers, and the successful scaling of its online games and charity lottery segments. In her seat11a.com presentation, CFO Andrea Behrendt highlights the successful execution of ZEAL’s long-term digital strategy, even in a challenging jackpot environment.H1 2025 Financial Highlights (vs. H1 2024): - Revenue: €101.5 million (+32.3%) - EBITDA: €35.4 million (+76%) - EBIT: €31.1 million (+92.5%) - Net profit after tax: €19.5 million (-47%, due to one-time tax gain in 2024) - EBITDA margin: 34.8% (vs. 26.2% in H1 2024)ZEAL’s core lottery business generated €90.9 million in revenue, while the games segment surged by 49%, reaching €6.7 million. Despite only two jackpot peaks vs. six in the prior-year period, the company maintained strong billings and successfully activated new customer cohorts, demonstrating the resilience of ZEAL’s customer acquisition strategies.Customer & Platform Growth: - Lottery billings: €527.3 million (+4%) - Monthly Active Users (lottery): 1.52 million (+12%) - Average billing per user: €58.03 (slightly down due to jackpot volatility) - Games MAUs: 26k (+32%) - Games ARPU: €42.40 (+15%)While new customer registrations were down 16% due to lower jackpot incentives, ZEAL still reached 499k new users, thanks to targeted brand marketing and platform engagement strategies. Cost-per-lead (CPL) rose to €46.93, reflecting broader media testing and inflation in media costs.Games & Platform Expansion:ZEAL now offers more than 480 online games, with strong usage growth and clear monetisation upside. The company continues to develop this vertical as a strategic pillar, targeting €14 million in annual games revenue in 2025.Traumhausverlosung Update: - 3rd draw concluded in June 2025, raising €1.6 million for charity - 4th draw (St. Peter-Ording) launched in September and shows very strong momentum - Total contributions to charity to date: €5.4 million - ZEAL expects over €30 million in billings from this segment in FY2025Operational Performance and Cost Dynamics: - Personnel costs rose 21% due to a 27% increase in headcount (from 195 to 247 FTE) and management restructuring - Marketing costs increased by 14%, reflecting stronger brand activity and market tests - Direct/indirect costs increased due to developer commissions, software, consultants, and one-off housing purchases associated with the raffle business - Despite these, EBITDA margin rose to 34.8%, highlighting solid operating leverage2025 Guidance Confirmed: - Revenue: €195–205 million - EBITDA: €55–60 million - Marketing spend: €60–70 million - Ongoing investments into charity lottery and online games▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Palfinger AG H1 2025: Key Takeaways
Palfinger AG H1 2025: Strategic Progress Amid Macroeconomic Headwinds
Presented by CFO Felix Strohbichler
In the first half of 2025, Palfinger AG showed solid strategic progress despite a challenging macro environment. CFO Felix Strohbichler reported a decline in revenue and earnings, as expected, but emphasised that order intake is up, the service business is growing, and the foundation is laid for a strong second half.
🟢 Key Highlights from H1 2025:
Revenue was €1,139.5 million, down slightly by -3.1% year-over-year
EBITDA came in at €136.7 million (-12.6%)
EBIT margin was 9.2%, holding relatively stable
Consolidated net result dropped to €50.1 million, down -26.7%
Free cash flow improved significantly to €28.3 million, confirming strong internal cash generation
Despite the earnings dip, Palfinger has laid the groundwork for a rebound. The order book remains robust, especially in EMEA, with stronger intake since Q4 2024. Felix Strohbichler highlights increased activity in Europe and the U.S., with local capacity being ramped up to meet demand.
🛠️ Service Business – A Strategic Growth Lever:
The service segment continues to shine, with the share of total business rising to 17.8% (up from 15.7% in 2023). This is aligned with Palfinger’s target of €700 million service revenue by 2030. Investments include:
A new sales and service hub in Madrid
A modernised site in Duisburg
A new Marine location in Singapore
🌍 Global Production Footprint & Market Position:
With 30 production sites worldwide and operations across Europe, North America, Latin America, APAC, and the marine sector, Palfinger reinforces its position as the global leader in lifting and crane solutions, offering everything from loader cranes and offshore systems to digital platforms.
Its industry diversification—spanning construction, logistics, recycling, forestry, housing, and rail—underpins resilience even in tougher cycles, providing a strong foundation for future growth.
📊 Balance Sheet & Shareholder Value:
Equity ratio improved to 36.2%
Gearing reduced to 89.6%, a significant improvement from 101.4% last year
In Q2 2025, 2.8 million treasury shares were placed, raising €100 million, earmarked for:
Growth in North America
Defence sector investment
Expansion of service operations
The increased free float enhances liquidity and potential ATX index inclusion.
📈 Outlook 2025 & Beyond:
Palfinger expects to recover revenue and EBIT losses in H2 2025, aiming to deliver the second-best year in company history. Key drivers include:
A recovering construction and logistics environment
Continued volume expansion in service and marine
Strong positioning in global infrastructure and rearmament programs (Ukraine reconstruction, RePower EU, U.S. Stargate, etc.)
2027 Targets Remain in Place:
€2.7 billion revenue
10% EBIT margin
>12% ROCE
🧭 Conclusion by CFO Felix Strohbichler:
“We are on track operationally, financially, and strategically. With improving order intake, strong cash flow, and targeted investments, we’re well-positioned to turn the second half into a strong finish and achieve our long-term goals.”
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Carl Zeiss Meditec AG Deep Dive
Carl Zeiss Meditec: China Strategy Deep Dive and Growth Outlook
Presented by Sebastian Frericks, Head of Group Finance & Investor Relations
In this comprehensive China-focused investor presentation, Sebastian Frericks, Head of Group Finance & Investor Relations at Carl Zeiss Meditec, provides a strategic deep dive into the company’s operations and growth opportunities in one of the world’s most dynamic and promising healthcare markets.
🇨🇳 China – A Strategic Growth Engine
China is Carl Zeiss Meditec’s largest single-country market, now contributing approximately 26% of group revenue — up from just 6% a decade ago. This growth has been driven by:
- Rapid urbanization
- Rising middle-income population
- High myopia prevalence
- Aging demographics fueling demand for cataract and retinal solutions
Despite short-term challenges such as anti-corruption reforms, post-COVID consumer sentiment softness, and volume-based procurement (VBP) schemes, Carl Zeiss Meditec has remained resilient. The long-term fundamentals in China remain intact and highly attractive.
🔍 Segment Highlights
👁 Refractive Surgery
ZEISS is the undisputed market leader in China with an estimated >50% market share
Over 1,200 installed VISUMAX femtosecond lasers, with more than 15% due for replacement
New platforms VISUMAX® 800 and PRESBYOND® launched for high-growth refractive and presbyopia treatments
SMILE procedure accounts for 70% of volume, significantly ahead of LASIK (30%)
Despite macro headwinds, market share continues to grow
👁 Intraocular Lenses (IOL) & Cataract Surgery
Fastest-growing surgical segment for ZEISS in China
IOL volumes growing ~20% CAGR in FY23/24, driven by VBP pricing reset and increased access
Strong performance in premium IOLs (multifocal & presbyopia-correcting), with ~30% growth
Significant runway to close the cataract surgery volume gap with the US
🧬 Retina & Surgical Solutions
ZEISS among the top 3 global players in posterior segment surgery
Integration of DORC expanding ZEISS’ retinal surgery workflow
New product approvals in FY24 enabling rollout in China
🏭 ZEISS Local Presence in China
ZEISS is deeply embedded in the Chinese healthcare ecosystem through:
Manufacturing facilities in Suzhou and Guangzhou
China-specific R&D capabilities and product design
Experienced local regulatory and clinical affairs teams
Extensive sales and service infrastructure across the country
Remarkably, ZEISS brand awareness in China exceeds that of its home market, Germany — a legacy of decades of optical innovation in telescopes, eyewear, and imaging systems.
📉 Addressing Short-Term Headwinds
VBP tenders have reduced prices (~40%) but expanded patient access
Post-COVID overstocking in refractive consumables has normalized
“Buy local” policies are offset by ZEISS’ Chinese manufacturing footprint
📈 Long-Term Strategy & Growth Levers
Promote full refractive portfolio, especially VISUMAX® 800 and PRESBYOND®
Accelerate premium IOL penetration and clear lens exchange programs
Expand DORC-based retinal surgery platform
Deepen localization to navigate regulatory and cost environments
Capitalize on brand strength, IP leadership, and ongoing innovation to stay ahead of domestic competitors
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
eDreams ODIGEO's FY 2025 Key Takeaways
eDreams ODIGEO FY25: Record Performance and the Future of Subscription-Based Travel
Presented by CFO David
In this in-depth video presentation, CFO David of eDreams ODIGEO — Europe’s largest online travel company and a global leader in dynamic packages — walks viewers through the company’s record-breaking FY25 financial results, strategic achievements and long-term growth outlook. The presentation highlights the successful completion of their 3.5-year transformation plan, the exponential growth of their Prime subscription model, and robust profitability metrics, positioning eDreams ODIGEO at the forefront of travel tech innovation.
🔹 A Game-Changing Strategic Transformation
CFO David begins by outlining the completion of the 3.5-year strategic roadmap launched in 2021, a plan that has fundamentally reshaped the company’s business model. This strategy, which focused on transitioning from a transactional, flight-centric platform to a subscription-based, customer-centric business, with Prime at its core, has been a game-changer for eDreams ODIGEO. Not only did it ensure stronger recurring revenue streams, but it also differentiated eDreams from competitors, setting the stage for the company’s future growth and success.
By FY25, the company successfully achieved — and in some cases exceeded — its long-term targets well ahead of schedule, despite the challenges posed by the COVID-19 pandemic. eDreams now operates on a solid foundation, with predictable and profitable growth levers, making it one of the few online travel businesses to generate both scale and resilience, a testament to its adaptability and strategic planning.
🔹 Record Financial Performance
CFO David then breaks down the FY25 numbers, revealing a year of record revenues, profitability, and margins:
Revenues exceeded expectations, reaching €621 million, representing a 10% year-on-year increase.
Adjusted EBITDA came in at €128 million, marking a 23% increase vs FY24 and reaffirming the effectiveness of the subscription model.
Record net income, with improvements in both absolute terms and margins, reflects operational efficiency and customer loyalty.
Margins have expanded thanks to AutoDue, dynamic packaging, and AI-driven personalisation throughout the booking journey. These innovations have enhanced the customer experience while improving unit economics.
🔹 Prime: The Heart of the Growth Engine
A cornerstone of the presentation is the phenomenal performance of eDreams Prime, the world’s first travel subscription platform. The subscriber base grew to 6.1 million members in FY25, up from 5.3 million the prior year — a growth of over 15%.
Prime customers are more loyal, generate higher lifetime value (LTV), and book more frequently, contributing significantly to profitability. The current focus is on monetisation and retention, with opportunities in cross-selling, hotel add-ons, and dynamic packages. Prime functions as both a retention tool and a data ecosystem, enabling targeted marketing and intelligent product development.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
BRAIN Biotech AG: Elevator Pitch von CFO Michael Schneiders
Ein Pionier der nachhaltigen industriellen Biotechnologie
In diesem überzeugenden Elevator Pitch stellt Michael Schneiders, CFO der BRAIN Biotech AG mit Sitz in Zwingenberg, Deutschland, das Unternehmen als Vorreiter in der nachhaltigen industriellen Biotechnologie vor. BRAIN nutzt die Natur als Blaupause, um einige der drängendsten Herausforderungen der industriellen Produktion weltweit zu lösen.
Biotechnologische Innovation für globale Herausforderungen
BRAIN wendet biotechnologische Prinzipien an, um die Effizienz, Nachhaltigkeit und Gesundheitsverträglichkeit industrieller Produktionsprozesse zu verbessern – insbesondere in den Bereichen Lebensmittel, Getränke und Life Sciences. Zu den Innovationen gehören Enzymlösungen zur Energieeinsparung, alternative Proteine zur Reduzierung von Monokulturen und Viehzucht sowie biobasierte Inhaltsstoffe – alles mit dem Ziel, die globale Ernährungssicherheit und das Wohlbefinden zu fördern.
Zwei zentrale Geschäftsbereiche
Das Unternehmen operiert in zwei zentralen Segmenten:
BRAIN Biocatalysts
Die Produktdivision erwirtschaftet rund 47,5 Millionen Euro Jahresumsatz und ein bereinigtes EBITDA von 5,1 Millionen Euro. Sie konzentriert sich auf Enzyme, Mikroorganismen und biobasierte Inhaltsstoffe, die vor allem in der Lebensmittelverarbeitung und anderen industriellen Anwendungen eingesetzt werden. Die Sparte ist profitabel, investiert rund 5 % des Umsatzes in F&E und verfolgt das mittelfristige Ziel, den Umsatz auf 100 Millionen Euro und die bereinigte EBITDA-Marge auf 15 % zu steigern – ein klares Signal für wachstumsorientierte Geschäftsentwicklung.
BRAIN BioIncubator
Der Innovationsarm des Unternehmens konzentriert sich auf die Entwicklung vielversprechender Biotech-Projekte, insbesondere in den Bereichen Lebensmittel, Getränke und Pharma. Im letzten Jahr wurden hier 7,1 Millionen Euro Umsatz erzielt. Der Bereich steht im Zentrum der langfristigen Wertschöpfungsstrategie von BRAIN, mit Fokus auf die Monetarisierung bahnbrechender Technologien und dem Aufbau margenstarker Lizenzpartnerschaften.
Ein vollständig integrierter Enzymlösungsanbieter
BRAIN deckt die gesamte Wertschöpfungskette in der Enzymentwicklung ab:
Entdeckung (in der Natur oder durch eigene Entwicklung)
Stammentwicklung und Expression (auf Basis von Bakterien, Pilzen oder Hefen)
Fermentation (im industriellen Maßstab am Standort Cardiff)
Enzymformulierung und weltweite Distribution
Drei Marktzugangsmodelle
Kunden werden über drei Go-to-Market-Kanäle bedient:
Produktvertrieb: vor allem an die Lebensmittel- und Getränkebranche (Milchprodukte, Backwaren, Wein, Stärke)
Auftragsforschung: kundenspezifische F&E-Lösungen
Auftragsentwicklung und -fertigung (CDMO): Unterstützung bei der Bioprozessoptimierung und industriellen Fermentation
Hochwertige BioIncubator-Projekte
CFO Schneiders hebt zwei aktuell kommerzialisierte Leuchtturmprojekte hervor:
Royalty-Pharma-Transaktion
BRAIN hat frühe Rechte an einem pharmazeutischen Wirkstoffkandidaten monetarisiert und dabei eine Vorabzahlung von 18,4 Millionen Euro erzielt – mit potenziellen Gesamterlösen von bis zu 138 Millionen Euro...
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
BRAIN Biotech AG Elevator Pitch: Key Takeaways
BRAIN Biotech AG: Elevator Pitch from CFO Michael Schneiders
A Pioneer in Sustainable Industrial Biotechnology
In this compelling elevator pitch from CFO Michael Schneiders of BRAIN Biotech AG, headquartered in Zwingenberg, Germany, the company positions itself as a pioneer in sustainable industrial biotechnology, utilising nature as a blueprint to tackle some of the world’s most pressing industrial production challenges.
Biotechnological Innovation for Global Challenges
BRAIN applies biotechnological principles to improve the efficiency, sustainability, and health impact of industrial production, especially in food, beverage, and life sciences. Its innovations include enzyme solutions that contribute to energy savings, alternative proteins that reduce the need for monocultures and livestock farming, and bio-based ingredients, all of which contribute to global food security and well-being.
Two Core Business Divisions
The company operates via two core divisions:
BRAIN Biocatalysts
A commercial products division generating approx. €47.5 million in annual revenues and €5.1 million in adjusted EBITDA. It focuses on enzymes, microorganisms, and bio-based ingredients used widely in processed food and other industrial applications. The segment is profitable, maintains a strong 5% R&D investment ratio, and aims to reach €100 million in sales with a 15% adjusted EBITDA margin in the medium term, demonstrating strong revenue growth.
BRAIN BioIncubator
The innovation arm is dedicated to incubating high-potential biotech projects, primarily in the space of food, beverage and pharmaceuticals. Last year, it generated €7.1 million in revenue. It is central to the company’s long-term value creation strategy, with a focus on monetising breakthrough technologies and entering high-margin licensing partnerships.
Fully Integrated Enzyme Solutions Provider
BRAIN is a fully integrated enzyme solutions provider covering the entire value chain:
- Discovery (in nature or via own engineering)
- Strain development and expression (bacteria, fungi, or yeast-based bio-factories)
- Fermentation (industrial-scale in Cardiff)
- Enzyme formulation and global distribution
Three Go-to-Market Channels
The company serves customers via three go-to-market channels:
- Product sales: Especially to the food & beverage sectors (dairy, baking, wine, starch)
- Contract research: Custom R&D for client-specific solutions
- Contract development and manufacturing (CDMO): Supporting client bioprocess optimisation and industrial fermentation
High-Value BioIncubator Projects
CFO Schneiders highlights two high-value BioIncubator projects now being commercialised:
Royalty Pharma Transaction
BRAIN monetised early-stage rights to an investigative pharmaceutical compound, securing €18.4 million upfront with potential total proceeds of up to €138 million.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
📲 Follow seat11a:
🔗 Website: https://seat11a.com
📢 LinkedIn: https://www.linkedin.com/company/seat11a
🐦 Twitter: https://x.com/seat11a_com
🎧 Spotify: https://open.spotify.com/show/1XXbzcQmY3fbeeoodYIO0H
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
BRAIN Biotech AG Q1 2024/25: Key Takeaways
BRAIN Biotech AG H1 FY 2024/25: Innovation Momentum and Strategic Focus
Presented by Michael Schneiders, Chief Financial Officer
In this strategic and transparent financial update, Michael Schneiders, Chief Financial Officer of BRAIN Biotech AG, guides investors through the company’s final H1 FY 2024/25 results, providing insights into both operational progress and long-term positioning in the industrial biotechnology sector.
Revenue Stability and Margin Strength
Despite macroeconomic challenges, BRAIN Biotech AG has demonstrated resilience, with group revenue reaching €27.3 million, a modest year-over-year increase of 1.5%. This growth was primarily driven by the BioScience segment, which posted double-digit growth, and the company maintained a solid gross margin of 31.6%, a testament to our favourable product mix and operational efficiency gains.
Segment Highlights
The BioScience division, focused on R&D services and tailor-made enzyme solutions, continues to thrive. With strong project demand and recurring customer business, this segment remains the primary growth engine and a testament to BRAIN’s unwavering commitment to innovation-driven strategy.
The BioIndustrial segment, which includes proprietary product sales, showed a temporary decline due to destocking effects in the nutritional ingredients business. However, CFO Michael Schneiders highlights that this is expected to normalize in the second half of the fiscal year.
Strategic Innovation: Akribion Genomics
One of the strategic highlights of the presentation is the continued progress in BRAIN’s genome editing platform, particularly within Akribion Genomics, a BRAIN subsidiary focused on CRISPR-based cell targeting technologies. The company recently strengthened its IP portfolio and is progressing toward preclinical validation, positioning itself for potential out-licensing and industrial applications.
Key Financial Metrics
- Adjusted EBITDA at €0.6 million, showing positive operational leverage
- Improved cost structure, with lower R&D and admin expenses compared to last year
- Cash and equivalents at €9.4 million, ensuring liquidity for innovation and growth
FY 2024/25 Outlook
BRAIN Biotech confirms its full-year 2024/25 guidance, expecting:
- Group revenue growth in the mid-single-digit percentage range
- Further expansion in the BioScience segment
- Strong progress on strategic partnerships and tech licensing models
Strategic Transformation and Growth Path
CFO Schneider emphasizes that BRAIN is transitioning from a pure service model to a dual-track model, combining revenue from both high-margin services and scalable biotech innovations. This strategic shift underscores the company’s focus on unlocking value through deep-tech enzyme engineering, sustainable bioprocesses, and advanced genome editing, instilling confidence in our future direction.
Conclusion: A Future-Driven Biotech Enabler
The presentation concludes with a confident outlook, reaffirming BRAIN Biotech’s ambition to become a leading enabler in industrial biotechnology, particularly in green transformation, food innovation, and medical bioengineering.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
JOST Werke SE Financial Results Q1 2025 | Regional Performance and Outlook with IR
JOST Werke SE Q1 2025: Key Takeaways
JOST Werke SE Q1 2025: Margin Expansion and Global Demand Resilience
Presented by Romy Acosta, Head of Investor Relations
In this sharp and informative investor presentation, Romy Acosta, Head of Investor Relations at JOST Werke SE, outlines the company’s Q1 2025 financial results, highlighting continued operational strength, margin improvement, and resilient global demand in a mixed macroeconomic climate.
Financial Performance Highlights
JOST Werke, a global leader in safety-critical systems for commercial vehicles, reported sales of €312.4 million in the first quarter of 2025, nearly stable year-on-year despite persistent economic headwinds in Europe. The company’s performance reflects solid customer demand, especially in the aftermarket and agricultural segments.
EBIT Margin Expansion and Profitability
A key positive highlight is the improvement in EBIT margin, which rose to 8.7% (up from 8.4% in Q1 2024). EBIT increased to €27.1 million, even as top-line growth remained flat. This margin expansion underscores cost discipline, improved operational efficiency, and a favourable business mix with increased contributions from high-margin regions and services.
Adjusted earnings per share (EPS) increased to €1.60, clearly reflecting our ability to maintain earnings momentum while managing global uncertainty. This achievement should instil confidence in our financial management.
Regional Performance Overview
Europe: The market is still challenging due to high inflation and cautious fleet investment, yet JOST maintained a stable position with robust aftermarket sales.
North America: Continued positive momentum supported by solid demand in OEM and aftermarket channels.
Asia-Pacific-Africa: A standout performer again, particularly due to strong agricultural equipment demand in India, which continues to be one of JOST’s fastest-growing markets.
Full-Year 2025 Guidance
Romy Acosta also reaffirms JOST’s guidance for FY 2025, which includes:
Stable or slightly increasing group sales
Further margin enhancement driven by mix and efficiency
High focus on free cash flow generation and disciplined capital expenditure
Strategic Growth Drivers
The company’s aftermarket and agricultural equipment divisions remain strategic growth drivers, supported by megatrends such as global logistics expansion, agricultural mechanisation, and fleet digitalisation.
Conclusion: Operational Resilience and Long-Term Focus
In closing, Acosta highlights JOST’s strong balance sheet, innovation roadmap, and ongoing commitment to delivering reliable components to truck and trailer manufacturers worldwide, with the flexibility to adapt to changing global conditions.
Q1 2025 confirms that JOST remains on track operationally, with resilience across all key regions and a clear focus on profitability and long-term growth.
▶️ Other videos:
Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/
Company Presentation: https://seat11a.com/investor-relations-company-presentation/
Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/
Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/
ESG Presentation: https://seat11a.com/investor-relations-esg/
T&C
This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
